专利号:US-11111208-B2 优先权日:2019-06-17 标题:Process for the preparation of safinamide mesylate intermediate 发明人:KOVI RAVISHANKER; KANNAPPAN JAYARAMAN; PATEL RAJESH A; PATEL DAXESHKUMAR PRAKASHBHAI 权利人:RK Pharma Solutions LLC 摘要:The present application provides methods for the synthesis of intermediates in the synthesis of Safinamide or a pharmaceutically acceptable salt thereof herein Safinamide Mesylate, that is substantially free of impurities.
专利号:WO-2016091228-A1 优先权日:2014-12-11 标题 :Substituted phenyltetrazole, its use and pharmaceutical preparation containing it 发明人:ROH JAROSLAV; NEMECEK JAN; HRABALEK ALEXANDR; KLIMESOVA VERA; KARABANOVICH GALINA; PAVEK PETR; SYCHRA PAVEL 权利人:UNIV KARLOVA 摘要:A nitro group-substituted phenyltetrazole of general formula (I) wherein R is selected from the group consisting of: H, C 1 -C 11 alkyl, phenyl- or phenyl- substituted in positions 2, 3, 4 or 5 by one or more electron-acceptor groups and/or by one or more electron-donor groups. These compounds can be prepared by easy synthesis and have significant activity against mycobacteria including their multidrug resistant strains. The invention provides also a pharmaceutical preparation having nitro group-substituted phenyltetrazole of formula (I) as the active ingredient, as well as the use of this nitro group-substituted phenyltetrazole as antituberculosis drug.
专利号:US-9676772-B2 优先权日:2013-07-25 标题 :Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use thereof 发明人:ZAJDEL PAWEL; GRYCHOWSKA KATARZYNA; PAWLOWSKI MACIEJ; PARTYKA ANNA; WESOLOWSKA ANNA; BOJARSKI ANDRZEJ J; POPIK PIOTR; KOS TOMASZ; SATALA GRZEGORZ; LAMATY FREDERIC; COLACINO EVELINA; MARTINEZ JEAN; SUBRA GILLES; BANTREIL XAVIER 权利人:CENTRE NAT RECH SCIENT; UNIV MONTPELLIER; UNIV JAGIELLONSKI; INST FARMAKOLOGII POLSKIEJ AKADEMII NAUK; Uniwersyter Jagiellonski 摘要:This invention concerns pyrroloquinoline derivatives as antagonists of 5-HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in schizophrenia, anxiety, depression, maniac depression, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, panic attacks, attention deficit hyperactivity disorder, attention deficit disorder, Parkinson's disease, Huntington's disease, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, obesity and type-2 diabetes, functional bowel disorder, Irritable Bowel Syndrome. The compounds have the general formula (XIV), wherein the symbols have the meanings given in the description.
专利号:CN-107879963-A 优先权日:2016-09-29 标题 :Synthesis methods of novel chiral ligands, metal chelates, various unnatural amino acids, Maravino and its key intermediates
专利号:JP-H06500076-A 优先权日:1990-07-18 标题 :Piperidine compounds, their synthesis and methods of use